Intervontions of Interest:
- etranacogene dezaparvovec (CSL Behring)
- valoctocogene roxaparvovec (Roctavian ™; BioMarin)
For questions, please contact Monica Frederick, Program Associate, at mfrederick@icer.org.
View the Key Stakeholder List.
Assessment Status
Open
Upcoming Milestone
Revised Scoping DocumentView
Intervontions of Interest:
For questions, please contact Monica Frederick, Program Associate, at mfrederick@icer.org.
View the Key Stakeholder List.
CTAF
The CTAF’s 2022 public meeting on gene therapies for hemophilia.
Public Comment Period
See Full Timeline
Public Comments
OpenView
Closed